SecBot SecBot
SECBOTREPLAY Home › Report › RLAY

RLAY · Two top executives at Relay Therapeutics, CEO Sanjiv Patel and…

Relay Therapeutics, Inc. · CLUSTER filed Sep 9, 2026 at 16:17 ET

At the news

NEUTRALIMPACT 4/10

CLUSTER filed Sep 9, 2026 at 16:17 ET

Two top executives at Relay Therapeutics, CEO Sanjiv Patel and President of R&D Donald Bergstrom, sold a combined $1.07M in open-market sales on September 8, 2026. While the dollar amount is modest relative to the $4.2B market cap (~0.03%), the cluster involves the CEO and President of R&D selling on the same day, which warrants attention. The stock has a 95% analyst buy rating and strong institutional support, but the insider sales introduce a note of caution against the bullish consensus.

  • CEO Sanjiv Patel sold 48,199 shares at $18.94 for $912,889 on September 8, 2026.
  • President of R&D Donald Bergstrom sold 8,530 shares at $18.97 for $161,814 on September 8, 2026.
  • CFO Thomas Catinazzo also sold 17,717 shares at $18.94 for $335,560 on September 8, 2026.
  • Total cluster value is $1.07M, representing approximately 0.03% of the $4.2B market cap.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access